Bain Capital Public Equity Management LLC purchased a new stake in Foundation Medicine Inc (NASDAQ:FMI) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 45,350 shares of the company’s stock, valued at approximately $3,093,000. Bain Capital Public Equity Management LLC owned about 0.13% of Foundation Medicine as of its most recent SEC filing.
Several other institutional investors have also made changes to their positions in the company. Chevy Chase Trust Holdings Inc. lifted its stake in shares of Foundation Medicine by 0.9% in the 4th quarter. Chevy Chase Trust Holdings Inc. now owns 1,068,293 shares of the company’s stock valued at $72,825,000 after purchasing an additional 9,152 shares during the last quarter. Discovery Group I LLC lifted its stake in Foundation Medicine by 0.9% during the 3rd quarter. Discovery Group I LLC now owns 836,986 shares of the company’s stock worth $33,647,000 after acquiring an additional 7,181 shares in the last quarter. Oppenheimer & Co. Inc. lifted its stake in Foundation Medicine by 5.8% during the 3rd quarter. Oppenheimer & Co. Inc. now owns 723,480 shares of the company’s stock worth $29,084,000 after acquiring an additional 39,390 shares in the last quarter. Vanguard Group Inc. lifted its stake in Foundation Medicine by 8.2% during the 2nd quarter. Vanguard Group Inc. now owns 631,339 shares of the company’s stock worth $25,096,000 after acquiring an additional 47,843 shares in the last quarter. Finally, State Street Corp lifted its stake in Foundation Medicine by 124.2% during the 2nd quarter. State Street Corp now owns 526,775 shares of the company’s stock worth $20,947,000 after acquiring an additional 291,815 shares in the last quarter. 32.88% of the stock is currently owned by institutional investors and hedge funds.
In other Foundation Medicine news, insider Vincent A. Miller sold 2,349 shares of the stock in a transaction dated Tuesday, January 2nd. The stock was sold at an average price of $64.00, for a total value of $150,336.00. Following the sale, the insider now owns 99,484 shares of the company’s stock, valued at approximately $6,366,976. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Vincent A. Miller sold 32,008 shares of the stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $76.87, for a total value of $2,460,454.96. The disclosure for this sale can be found here. Insiders sold a total of 277,852 shares of company stock worth $18,786,273 in the last ninety days. 2.70% of the stock is owned by corporate insiders.
Shares of Foundation Medicine Inc (FMI) opened at $82.60 on Tuesday. The company has a debt-to-equity ratio of 1.90, a current ratio of 1.86 and a quick ratio of 1.67. The stock has a market capitalization of $2,990.00, a PE ratio of -18.31 and a beta of -0.21. Foundation Medicine Inc has a 12-month low of $29.90 and a 12-month high of $87.10.
Foundation Medicine (NASDAQ:FMI) last posted its quarterly earnings results on Wednesday, March 7th. The company reported ($1.05) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.97) by ($0.08). The company had revenue of $48.90 million during the quarter, compared to analyst estimates of $48.69 million. Foundation Medicine had a negative net margin of 105.60% and a negative return on equity of 207.73%. Foundation Medicine’s revenue for the quarter was up 69.8% on a year-over-year basis. During the same period in the prior year, the business earned ($1.02) EPS. equities research analysts expect that Foundation Medicine Inc will post -3.99 earnings per share for the current fiscal year.
WARNING: “Bain Capital Public Equity Management LLC Purchases Shares of 45,350 Foundation Medicine Inc (FMI)” was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this news story on another website, it was stolen and republished in violation of US & international copyright & trademark laws. The correct version of this news story can be accessed at https://www.americanbankingnews.com/2018/03/13/bain-capital-public-equity-management-llc-purchases-shares-of-45350-foundation-medicine-inc-fmi.html.
About Foundation Medicine
Foundation Medicine, Inc is a molecular information company. The Company sells products that are enabled by its molecular information platform to physicians and biopharmaceutical companies. It is engaged in the business of delivering molecular information about cancer to its customers. Its platform includes various methods and algorithms for analyzing specimens across various types of cancer.
Want to see what other hedge funds are holding FMI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Foundation Medicine Inc (NASDAQ:FMI).
Receive News & Ratings for Foundation Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Foundation Medicine and related companies with MarketBeat.com's FREE daily email newsletter.